Overview of Share Repurchase Program
In a move reflecting its solid commitment to enhancing shareholder value, dsm-firmenich, a leader in nutrition, health, and beauty, has rolled out an ambitious share repurchase program. This initiative focuses on buying back shares with a total authorized amount of €1 billion, marking a significant step for the company. The program, which commenced with an initial investment of €500 million, highlights dsm-firmenich's strategic approach to reducing issued capital and rewarding its shareholders.
Details of the Share Repurchase
First launched on April 1, 2025, the program initially aimed to repurchase ordinary shares worth €580 million. This amount was strategically earmarked with €80 million allocated to meet commitments related to the company’s share-based compensation plans, while the remaining €500 million was designated for reducing the issued capital. The company recently increased the scope of the program to €1,080 million following the successful divestment of its stake in the Feed Enzymes Alliance.
Recent Transactions
As part of its commitment to transparency, dsm-firmenich shared that between September 1 and September 5, 2025, a total of 492,313 shares were repurchased at an average price of €82.41, totaling €40.6 million. This initiative reflects the company’s ongoing efforts to strengthen its financial footing and enhance shareholder confidence. To date, approximately 7,759,859 shares have been repurchased under this program, amounting to an impressive €698.3 million, at an average price of €89.98 per share. The share repurchase program is set to conclude by January 30, 2026.
Strategic Goals for the Future
dsm-firmenich's proactive approach goes beyond immediate financial gains, as the company aims to position itself for future growth. The significant capital allocation for the repurchase initiative is not just about decreasing share volume but also reinforcing the company’s long-term vision to thrive amid changing market dynamics. As the global faced challenges, dsm-firmenich is dedicated to ensuring that it retains a competitive edge while catering to the evolving needs of its customers.
Commitment to Innovation
Indeed, innovation remains at the core of dsm-firmenich’s ethos. The company continuously seeks to provide solutions that benefit not only consumers but also contribute positively to the planet. By leveraging natural and renewable ingredients along with their renowned scientific capabilities, dsm-firmenich is well-positioned to drive sustainability and improve the quality of life for billions worldwide.
For Inquiries and Additional Information
Should you have further questions or require additional insights regarding the share repurchase program or other corporate initiatives, dsm-firmenich invites you to reach out. The investor relations contact can provide further details. For media inquiries, please contact the designated media relations team.
Investor Relations Contact
If you have inquiries relating to dsm-firmenich's investor relations, please email investors@dsm-firmenich.com.
Media Relations Contact
For media-related inquiries, feel free to send an email to media@dsm-firmenich.com.
Frequently Asked Questions
What is the purpose of dsm-firmenich's share repurchase program?
The program aims to cover share plans and reduce issued capital, enhancing shareholder value.
How much has dsm-firmenich committed to the share repurchase?
The company has authorized €1,080 million for its share repurchase program, with significant funds already utilized.
What has been the recent activity in the repurchase program?
Recently, dsm-firmenich repurchased 492,313 shares at an average price of €82.41, totaling €40.6 million.
When is the program expected to conclude?
The share repurchase program is set to finish no later than January 30, 2026.
How can investors contact dsm-firmenich for more information?
Investors can reach out via email at investors@dsm-firmenich.com for any inquiries.
